Trial Profile
A Definitive Bioequivalence Study of ORTHO EVRA Exhibiting Faster Equilibration Profile and Currently Marketed ORTHO EVRA in Healthy Female Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2008
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norelgestromin (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 06 Nov 2008 New trial record.